The Stockholm School of Economics would like to congratulate the winners of the The Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel 2021. The price goes to David Card, Joshua D. Angrist and Guido W. Imbens.

Fredsaktivister och miljökämpar utmanar nu storbolagen på deras egen spelplan. Men går det att förändra världen genom att köpa aktier?

I en nyligen publicerad Score-rapport skriven av Kristina Tamm Hallström och Malin Dahl presenteras resultaten från en explorativ studie gjord av en understuderad granskningspraktik: den statliga marknadskontrollen.

Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation milieu that facilitates the introduction of more precise prevention and treatment in cancer care. The research institute SIR at the SSE is the coordinator Vision Zero Cancer.

For the fourth year in a row, Stockholm School of Economics has given out the Alumni of the Year Award and, for the first time ever, the Young Alumni of the Year Award. In 2021, the Alumni of the Year Award is presented to Åsa Riisberg, Investor and Board Member, and the Young Alumni of the Year Award is presented to Marina Dirks, Director - Global Sustainability at Tiffany & Co.

CIVICA - A growing number of students and (post)doctoral researchers across the alliance are benefitting from the newly launched programmes and offers.

Replication of existing research is considered an essential practice of the scientific process as – ideally – it promotes robust results and gradually disposes of those that fail to hold up to further scrutiny. However, in his newly published paper, SSE PhD student Felix Schafmeister finds that replication failure and success do not affect citation dynamics.

Join Mistra Center for Sustainable Markets (Misum) on October 8 for our second Annual Forum, which will examine the topic of ‘Responding to climate change - challenges and possible solutions’ with internationally renowned scholars as well as experts from the world of finance and high-emitting industries.

Forskningsinstitutet SIR vid Handelshögskolan i Stockholm är koordinator för Nollvision cancer och för den nya innovationsmiljön ”Test Bed Sweden for Clinical Trials and Implementation of Precision Health in Cancer Care”, som har beviljats finansiering i fem år av Vinnova och som kommer att ingå i det nationella strategiska innovationsprogrammet SWElife.